These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 17582508

  • 1. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board.
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
    Gonzalez-Pinto A, Vieta E, Reed C, Novick D, Barraco A, Aguado J, Haro JM.
    J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK, Emblem Advisory Board.
    Nord J Psychiatry; 2009 Jan; 63(4):285-91. PubMed ID: 19140076
    [Abstract] [Full Text] [Related]

  • 9. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J, EMBLEM Advisory Board.
    J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
    [Abstract] [Full Text] [Related]

  • 10. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.
    J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 12. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
    Novick D, Reed C, Haro JM, Gonzalez-Pinto A, Perrin E, Aguado J, Tohen M.
    Int Clin Psychopharmacol; 2010 Sep; 25(5):257-63. PubMed ID: 20531011
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.
    BMC Psychiatry; 2012 Dec 17; 12():228. PubMed ID: 23244301
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Dec 17; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.